Market Surveys Sample Clauses

Market Surveys. Human Resources will conduct a market survey of the salaries paid in established market cities for job classifications comparable to those held by Unit Employees, following those cities’ post-July 1, 2017 salary adjustments, and no later than December 31, 2017. Human Resources will determine the “75th percentile” of the salary maximums paid. The 75th percentile will be calculated as the average between the median maximum salary of the established market cities and the highest-paid maximum salary of those same market cities. Any Unit Employee whose base salary is below the newly established range minimum from the December 2017 market survey for his/her classification will receive a salary increase to that new minimum to be effective in the pay period this MOU is ratified and approved by City Council. Human Resources will conduct a second market survey of the salaries paid in established market cities for job classifications comparable to those held by Unit Members, following those cities’ post-July 1, 2019 salary adjustments, and no later than November 30, 2019. Human Resources will determine the “75th percentile” of the salary maximums paid. The 75th percentile will be calculated as the average between the median maximum salary of the established market cities and the highest-paid maximum salary of those same market cities. Any Unit Employee whose base salary is below the newly established range minimum from the November 2019 market survey for his/her classification will receive a salary increase to that new minimum to be effective in the first pay period ending in January of 2020. If an adjustment to a salary range causes the maximum of the range to fall below the existing maximum, the actual salary of any employee who was being paid above the new, lower maximum will be maintained (“red-lined”) until further market movement increases the maximum beyond the maintained amount.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Market Surveys. Market surveys and any other tenant information;
Sample 1Sample 2
Market Surveys. One ‘market survey was agreed for Nigeria in 2015. We agreed the following proposal: [activity title] Rapid market and processing infrastructure assessment Elements (draft ToRs): • Quickly assess dead or under-­‐performing operations in target states • Identify market segment ‘best bets’ • Propose upgrading (for PPP) • Identify potential for technical support tie in (1.1) • Identify suitable training activities • Look for potential fabricator champions (see below) • Look for turn-­‐around opportunities • Assess investment costs for a matching grant • Minimum investment cost for upgrading • Break-­‐even • Make a standard approach for roll-­‐out to other states Set this up as soon as possible (planned for Sept – but earlier if possible?) Notes: We will need help from IFAD gaining entry to some of these businesses and with logistical support
Sample 1
Market Surveys. During the term of the Agreement, Party B shall provide Party A with detailed, prompt market information, and shall provide a report of the relevant information for Party A in accordance with the latter’s requirements each term (“term report”), within thirty (30) days after the end of the term.
Sample 1
Market Surveys. Each party hereto may, at its discretion and expense, undertake such market surveys, research or analyses relating to ELDEPRYL Brand as it deems fit, and such surveys, research or analyses shall remain the property of the party undertaking same. Each party shall make such surveys, research and analyses specifically relating to ELDEPRYL Brand available to the other party at no cost to that other party. Somerset may request that CoCensys undertake market surveys, research or analyses relating to ELDEPRYL Brand and CoCensys may, in its sole discretion, elect to undertake such surveys, research or analyses. [ * ].
Sample 1
Market Surveys. We propose a small study of the market to assess the potential for a range of cassava products (see 2.3 below).
Sample 1
Market Surveys. Each party hereto may, at its discretion and expense, -------------- undertake such market surveys, research or analyses relating to the Product as it deems fit, and such surveys, research or analyses shall remain the property of the party undertaking same. Each party shall make such surveys, research and analyses specifically relating to the Product available to the other party at no cost to that other party. Schein may request that MGI undertake market surveys, research or analyses relating to the Product and MGI may, in its sole discretion, elect to undertake such surveys, research or analyses.
Sample 1
AutoNDA by SimpleDocs

Related to Market Surveys

  • Surveys Each Borrower shall submit the Ship owned by it regularly to all periodical or other surveys which may be required for classification purposes and, if so required by the Security Trustee provide the Security Trustee, with copies of all survey reports.

  • EU SURVEY 5.1. The participant shall complete and submit the online EU Survey after the mobility abroad within 30 calendar days upon receipt of the invitation to complete it.

  • Title Insurance and Surveys Buyer, at its sole cost and expense, may procure owner’s title insurance policies (the “Title Policies”) from Title Company with respect to the Owned Real Property or the Leased Real Property insuring title subject only to the Permitted Liens and such other general title exceptions as may be raised by the Title Company; provided, that Buyer’s ability or inability to obtain title insurance from the Title Company on the Owned Real Property or the Leased Real Property shall not result in an adjustment to the Purchase Price. If Buyer requests extended coverage policies or any endorsements to the Title Policies, Buyer shall also be responsible for the cost of such extended coverage and endorsements and the delivery of any documentation required by the Title Company in connection with the issuance of such extended coverage and endorsements (including surveys or zoning reports), however, Seller shall deliver the documentation required by the Title Company in connection therewith as described below. At Buyer’s request, Seller and its Affiliates shall cooperate with and assist Buyer with any reasonable request in Buyer’s efforts to obtain the Title Policies and shall execute and deliver to the Title Company such affidavits, certificates and other documentation as are customary and reasonably requested to cause the Title Company to issue CLTA Standard Coverage Policy – 1990 for the Owned Real Property or the Leased Real Property (including assistance to obtain a “non-imputation” or similar endorsement), provided that no such cooperation or assistance and nothing in such affidavits, certificates or documentation shall require Seller or its Affiliates to incur any Obligations to any Person that are not otherwise expressly set forth in this Agreement. Notwithstanding the preceding, Seller shall use Commercially Reasonable Efforts to provide, in support of any such “non-imputation” or similar endorsement, a legal opinion to the Title Company from the general counsel of the Company, subject to customary assumptions and qualifications, as to such counsel’s opinion, without additional inquiry, as to the status of the title rights of the Company to the Owned Real Property lying within the boundary fence of the Refinery. In no event shall Seller be obligated to seek estoppel certificates in connection with any of the Leased Real Properties. Prior to Closing, Buyer may, at its sole cost and expense, obtain and update any surveys pertaining to the Owned Real Property or the Leased Real Property; provided, however, that any such surveys and survey updates shall be performed by a surveyor acceptable to Seller, the approval of which shall not be unreasonably withheld, conditioned or delayed. Neither Buyer’s or any of its lenders’ receipt of any new or updated surveys shall constitute a condition to Closing or form the basis for delaying Closing; however, Seller agrees to reasonably cooperate with Buyer prior to the Closing to permit Buyer to attempt to procure any surveys of the Real Property Interests that Buyer reasonably deems necessary, all at Buyer’s sole risk, cost and expense.

  • Survey Buyer may obtain a survey of the Property before the Closing to assure that there are no defects, encroachments, overlaps, boundary line or acreage disputes, or other such matters, that would be disclosed by a survey ("Survey Problems"). The cost of the survey shall be paid by the Buyer. Not later than business days prior to the Closing, Buyer shall notify Seller of any Survey Problems which shall be deemed to be a defect in the title to the Property. Seller shall be required to remedy such defects within business days and prior to the Closing. If Seller does not or cannot remedy any such defect(s), Buyer shall have the option of canceling this Agreement, in which case the Xxxxxxx Money shall be returned to Buyer.

  • Title Reports With respect to each Closing Date Mortgaged Property listed in Part B of Schedule 4.1N annexed hereto, a title report issued by the Title Company with respect thereto, dated not more than 30 days prior to the Closing Date and satisfactory in form and substance to Administrative Agent;

  • Topographic Survey 3.1 Notify affected property owners of pending survey.

  • Eye Examinations For all covered employees required to use VDTs on average at least two (2) hours per day, MUNI will provide a base line eye examination at the Occupational Safety and Health facility ("OSH"), followed by an eye examination at OSH every two years.

  • Secondary Market Trading Survey Until such time as the Public Securities are listed or quoted, as the case may be, on the New York Stock Exchange, the American Stock Exchange or quoted on the Nasdaq National Market, or until such earlier time upon which the Company is required to be liquidated, the Company shall engage Xxxxxxxx Xxxxxx ("GM"), for a one-time fee of $5,000 payable on the Closing Date , to deliver and update to the Underwriters on a timely basis, but in any event on the Effective Date and at the beginning of each fiscal quarter, a written report detailing those states in which the Public Securities may be traded in non-issuer transactions under the Blue Sky laws of the fifty States ("Secondary Market Trading Survey").

  • Title Report If no Additional Mortgage Policy is required with respect to such Additional Mortgaged Property, a title report issued by the Title Company with respect thereto, dated not more than 30 days prior to the date such Additional Mortgage is to be recorded and satisfactory in form and substance to Administrative Agent;

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

Time is Money Join Law Insider Premium to draft better contracts faster.